MedTrace Logo

Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding

NCT00966355 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1034

Last updated 2018-03-19

Study results available
· View outcomes & findings →

Summary

This study is performed to compare the efficacy of terlipressin, somatostatin, and octreotide in patients with variceal bleeding for the control of variceal bleeding in combination with endoscopic therapy.

Conditions

  • Variceal Bleeding, Cirrhosis

Interventions

DRUG

Terlipressin

loading with 2 mg IV, and then 1 mg IV every 4 hours for 5 days

DRUG

Somatostatin

loading with 250 microgram IV, and then 250 microgram/hour continuous IV for 5 days

DRUG

Octreotide

loading with 50 microgram IV, and then 25 microgram/hour continuous IV for 5 days

Sponsors & Collaborators

  • Korea University

    lead OTHER

Principal Investigators

  • Soon Ho Um, Prof · Korea University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00966355 on ClinicalTrials.gov